{"id":"https://genegraph.clinicalgenome.org/r/45802e0e-b9cd-4012-937a-7baa958f2eadv2.1","type":"EvidenceStrengthAssertion","dc:description":"The PKD2 gene has been associated with autosomal dominant polycystic kidney disease in over 15 probands in 6 curated publications. PKD2 was first associated with this disease in humans in 1996 (Mochizuki et al.). Variants in this gene segregate with disease and can occur de novo.  The mechanism for disease is known to be loss of function. 53 unique variants (missense, in-frame indel, nonsense, frameshift, large deletion and complex rearrangements) have been classified as Pathogenic in ClinVar, 30 of which are frameshift, nonsense or canonical splice changes. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease association is supported by ample experimental evidence including expression studies, biochemical function, protein interactions and animal models that recapitulate the human disease. Evidence to support a biallelic PKD2 phenotype in humans has been reviewed, but there is currently insufficient literature available to support an autosomal recessive gene-disease relationship (PMIDs: 22114106, 33168999). In summary, PKD2 is definitively associated with autosomal dominant polycystic kidney disease. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen General Gene Curation Working Group on 5/22/2019 (SOP Version 6).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/45802e0e-b9cd-4012-937a-7baa958f2ead","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ae0ae123-be04-4ba2-b685-594ca47a3467","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:sopChange"},{"id":"cg:summaryChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ae0ae123-be04-4ba2-b685-594ca47a3467_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2023-12-08T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ae0ae123-be04-4ba2-b685-594ca47a3467_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2023-12-15T14:05:49.610Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae0ae123-be04-4ba2-b685-594ca47a3467_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc1d7b62-31db-4c08-bf94-041658dce541","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc1d7b62-31db-4c08-bf94-041658dce541_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29529603","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e0c9383-7b49-44c5-a405-58538dfa85df","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.1984A>C (p.Thr662Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357623218"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/79d0595e-236d-405d-8395-d44e9713842e","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79d0595e-236d-405d-8395-d44e9713842e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","allele":{"id":"https://genegraph.clinicalgenome.org/r/5941ac6c-7f40-47e2-b87a-2d0f3f654bfc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.2159del (p.Asn720IlefsTer17)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/440144"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e4b5f933-0542-4f3e-9509-4c7852ff9f21","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4b5f933-0542-4f3e-9509-4c7852ff9f21_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b663f7c-ee8d-4cb9-bd7f-0a4a0845c5a6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.203dup (p.Ala69GlyfsTer23)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/477627"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bf3a947e-10ba-4edf-b00d-f5003f7a8555","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf3a947e-10ba-4edf-b00d-f5003f7a8555_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","allele":{"id":"https://genegraph.clinicalgenome.org/r/2554e0a1-af31-4190-a9e1-e80a80d2fe0a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.1066G>C (p.Ala356Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357633188"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/58911692-13a8-4dca-b964-78b523431b80","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58911692-13a8-4dca-b964-78b523431b80_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","allele":{"id":"https://genegraph.clinicalgenome.org/r/112d933a-ccea-4796-8c75-332f22af00bc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.1249C>T (p.Arg417Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357615936"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2929328c-407a-49e8-9ef4-f64a9a43dc97","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2929328c-407a-49e8-9ef4-f64a9a43dc97_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326320","allele":{"id":"https://genegraph.clinicalgenome.org/r/86e636d6-a326-48e6-b96f-45cddfbaa168","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.1240T>G (p.Trp414Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357615896"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/48678a94-eccc-4c4b-8fc8-cde9a92fbe1d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48678a94-eccc-4c4b-8fc8-cde9a92fbe1d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a8e21e5-f219-4c2e-aad9-d8a3daf7ad1e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.1213C>T (p.Gln405Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/13519"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ae0ae123-be04-4ba2-b685-594ca47a3467_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2793cabd-b972-4e76-9ab3-84e873966b37_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"C85","family":{"id":"https://genegraph.clinicalgenome.org/r/2793cabd-b972-4e76-9ab3-84e873966b37","type":"Family","rdfs:label":"C85","member":{"id":"https://genegraph.clinicalgenome.org/r/b4a55b55-3598-4ccc-81a2-eaef8b531b3c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"C85-proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/82fa2ba8-7532-4d1e-81fb-dd4c548a2e46","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.1753C>T (p.Gln585Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357622681"}},"detectionMethod":"The 15 coding exons of the PKD2 gene and the associated splice donor and accepted sites were amplified by polymerase chain reaction (PCR). Automated sequencing of PCR products was performed on an ABI310 DNA sequencer (Perkin Elmer, Norwalk, CT, USA) using the cycle-sequencing method.","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"Linkage studies were performed with PKD1- and PKD2-linked markers to confirm PKD2 gene segregation.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/2132fd7b-d015-435f-bb51-e67914f33734_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","allele":{"id":"https://genegraph.clinicalgenome.org/r/82fa2ba8-7532-4d1e-81fb-dd4c548a2e46"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/b4a55b55-3598-4ccc-81a2-eaef8b531b3c"}},{"id":"https://genegraph.clinicalgenome.org/r/7c63552c-4e15-4c8a-9602-4f2941ac70dd_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","rdfs:label":"Family 1601 - Segregation Scoring","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/7c63552c-4e15-4c8a-9602-4f2941ac70dd","type":"Family","rdfs:label":"Family 1601 - Segregation Scoring","ethnicity":{"id":"cg:NotHispanicOrLatino"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/39c462c2-0700-4e94-9770-ed02007157c9_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","rdfs:label":"Family 1605 - Segregation Scoring","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/39c462c2-0700-4e94-9770-ed02007157c9","type":"Family","rdfs:label":"Family 1605 - Segregation Scoring","ethnicity":{"id":"cg:NotHispanicOrLatino"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/c4ac788f-4b5b-4c8b-9b98-d8bbaa59899d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"C113","family":{"id":"https://genegraph.clinicalgenome.org/r/c4ac788f-4b5b-4c8b-9b98-d8bbaa59899d","type":"Family","rdfs:label":"C113","member":{"id":"https://genegraph.clinicalgenome.org/r/9ef2f499-2a9c-4124-a297-1872266eeaf8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"C113-proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/91f19d12-ac1d-4a20-ae8e-44836626171c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.2511_2512delinsC (p.Glu837AspfsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658683083"}},"detectionMethod":"The 15 coding exons of the PKD2 gene and the associated splice donor and accepted sites were amplified by polymerase chain reaction (PCR). Automated sequencing of PCR products was performed on an ABI310 DNA sequencer (Perkin Elmer, Norwalk, CT, USA) using the cycle-sequencing method.","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"Linkage studies were performed with PKD1- and PKD2-linked markers to confirm PKD2 gene segregation","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1cbe10bb-9dba-45e4-b630-cb4bfa9e6256_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","allele":{"id":"https://genegraph.clinicalgenome.org/r/91f19d12-ac1d-4a20-ae8e-44836626171c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/9ef2f499-2a9c-4124-a297-1872266eeaf8"}},{"id":"https://genegraph.clinicalgenome.org/r/6687ffaf-df99-4938-918a-ba645ed7e3b1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","rdfs:label":"Family 1601","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/6687ffaf-df99-4938-918a-ba645ed7e3b1","type":"Family","rdfs:label":"Family 1601","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/4c24ac07-f548-482a-802d-646822a0675d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","rdfs:label":"1601","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a8e21e5-f219-4c2e-aad9-d8a3daf7ad1e"},"detectionMethod":"We used reverse-transcribed RNA and genomic DNA templates to generate polymerase chain reaction (PCR) products for single-strand conformational analysis (SSCA).  Genomic PCR products of SSCA variants were subjected to direct sequencing.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"PKD2 family shown to have linkage to the PKD2-region.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/48678a94-eccc-4c4b-8fc8-cde9a92fbe1d_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"proband":{"id":"https://genegraph.clinicalgenome.org/r/4c24ac07-f548-482a-802d-646822a0675d"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b41a265c-dd6a-4b30-a98d-f3c93778346e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"C21","family":{"id":"https://genegraph.clinicalgenome.org/r/b41a265c-dd6a-4b30-a98d-f3c93778346e","type":"Family","rdfs:label":"C21","member":{"id":"https://genegraph.clinicalgenome.org/r/cf024857-05f1-48e9-970d-30fa484ebf7a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"C21-proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/112d933a-ccea-4796-8c75-332f22af00bc"},"detectionMethod":"The 15 coding exons of the PKD2 gene and the associated splice donor and accepted sites were amplified by polymerase chain reaction (PCR). Automated sequencing of PCR products was performed on an ABI310 DNA sequencer (Perkin Elmer, Norwalk, CT, USA) using the cycle-sequencing method.","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"Linkage studies were performed with PKD1- and PKD2-linked markers to confirm PKD2 gene segregation.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/58911692-13a8-4dca-b964-78b523431b80_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/cf024857-05f1-48e9-970d-30fa484ebf7a"}},{"id":"https://genegraph.clinicalgenome.org/r/c04deba1-9617-4be7-b19a-8769d8260258_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"6138","family":{"id":"https://genegraph.clinicalgenome.org/r/c04deba1-9617-4be7-b19a-8769d8260258","type":"Family","rdfs:label":"6138","member":{"id":"https://genegraph.clinicalgenome.org/r/b5fb36a1-ee32-49e8-b815-8b7ef16cd84c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"6138-proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/9d764a3a-7418-4215-aa46-9228ac0e71dc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.1367_1380delinsTGAAATTGCC (p.Gln456LeufsTer6)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658683084"}},"detectionMethod":"The 15 coding exons of the PKD2 gene and the associated splice donor and accepted sites were amplified by polymerase chain reaction (PCR). Automated sequencing of PCR products was performed on an ABI310 DNA sequencer (Perkin Elmer, Norwalk, CT, USA) using the cycle-sequencing method.","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"Linkage studies were performed with PKD1- and PKD2-linked markers to confirm PKD2 gene segregation.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d9422bac-82e0-427b-b413-9238ca60161f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","allele":{"id":"https://genegraph.clinicalgenome.org/r/9d764a3a-7418-4215-aa46-9228ac0e71dc"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/b5fb36a1-ee32-49e8-b815-8b7ef16cd84c"}},{"id":"https://genegraph.clinicalgenome.org/r/10dd4ac0-441b-4bbc-aed4-21b8db67f23e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"6019","family":{"id":"https://genegraph.clinicalgenome.org/r/10dd4ac0-441b-4bbc-aed4-21b8db67f23e","type":"Family","rdfs:label":"6019","member":{"id":"https://genegraph.clinicalgenome.org/r/a4ce4c26-2d33-4d15-aecb-210e8a4242a9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"6019-proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/5941ac6c-7f40-47e2-b87a-2d0f3f654bfc"},"detectionMethod":"The 15 coding exons of the PKD2 gene and the associated splice donor and accepted sites were amplified by polymerase chain reaction (PCR). Automated sequencing of PCR products was performed on an ABI310 DNA sequencer (Perkin Elmer, Norwalk, CT, USA) using the cycle-sequencing method.","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"Linkage studies were performed with PKD1- and PKD2-linked markers to confirm PKD2 gene segregation","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/79d0595e-236d-405d-8395-d44e9713842e_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a4ce4c26-2d33-4d15-aecb-210e8a4242a9"}},{"id":"https://genegraph.clinicalgenome.org/r/21819dc4-85f8-4984-a204-0aa3f77888da_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"P326","family":{"id":"https://genegraph.clinicalgenome.org/r/21819dc4-85f8-4984-a204-0aa3f77888da","type":"Family","rdfs:label":"P326","member":{"id":"https://genegraph.clinicalgenome.org/r/1afc8ce5-dd19-4ba9-9e32-80d5962167d7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"P326-proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b663f7c-ee8d-4cb9-bd7f-0a4a0845c5a6"},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/e4b5f933-0542-4f3e-9509-4c7852ff9f21_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/1afc8ce5-dd19-4ba9-9e32-80d5962167d7"}},{"id":"https://genegraph.clinicalgenome.org/r/ec9c7ac2-4347-4bc2-8173-342c177a8486_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9573526","rdfs:label":"TOR-PKD77- Segregation Scoring","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/ec9c7ac2-4347-4bc2-8173-342c177a8486","type":"Family","rdfs:label":"TOR-PKD77- Segregation Scoring"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":11,"publishedLodScore":4.55,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e46e91d6-7ec7-4029-a327-d59a2e93eb0a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"C76","family":{"id":"https://genegraph.clinicalgenome.org/r/e46e91d6-7ec7-4029-a327-d59a2e93eb0a","type":"Family","rdfs:label":"C76","member":{"id":"https://genegraph.clinicalgenome.org/r/2fb28a65-b9cb-4f83-ac11-80c1c035c3a9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10411676","rdfs:label":"C76-proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/2554e0a1-af31-4190-a9e1-e80a80d2fe0a"},"detectionMethod":"The 15 coding exons of the PKD2 gene and the associated splice donor and accepted sites were amplified by polymerase chain reaction (PCR). Automated sequencing of PCR products was performed on an ABI310 DNA sequencer (Perkin Elmer, Norwalk, CT, USA) using the cycle-sequencing method.","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"Linkage studies were performed with PKD1- and PKD2-linked markers to confirm PKD2 gene segregation.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/bf3a947e-10ba-4edf-b00d-f5003f7a8555_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/2fb28a65-b9cb-4f83-ac11-80c1c035c3a9"}},{"id":"https://genegraph.clinicalgenome.org/r/828e253b-e9b0-4284-b0cc-4d46d30e59fc_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","rdfs:label":"Family 97","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/828e253b-e9b0-4284-b0cc-4d46d30e59fc","type":"Family","rdfs:label":"Family 97","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/13241cb1-8b01-47b6-bb0a-1825d61ec84a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","rdfs:label":"97","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a66a832-f6f0-4d3d-a2b9-13377d9d63c6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.1139G>A (p.Trp380Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/13517"}},"detectionMethod":"We used reverse-transcribed RNA and genomic DNA templates to generate polymerase chain reaction (PCR) products for single-strand conformational analysis (SSCA).  Genomic PCR products of SSCA variants were subjected to direct sequencing.","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"PKD2 family shown to have linkage to the PKD2-region.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c8fbb192-024a-4102-aa42-1a7c8241b8c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a66a832-f6f0-4d3d-a2b9-13377d9d63c6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":10,"proband":{"id":"https://genegraph.clinicalgenome.org/r/13241cb1-8b01-47b6-bb0a-1825d61ec84a"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/76f7e42c-02ea-4fde-860d-36366f2a47ec_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9573526","rdfs:label":"TOR-PKD77","family":{"id":"https://genegraph.clinicalgenome.org/r/76f7e42c-02ea-4fde-860d-36366f2a47ec","type":"Family","rdfs:label":"TOR-PKD77","member":{"id":"https://genegraph.clinicalgenome.org/r/395ecbff-c2d0-4fce-8cf5-4e4bc69f0084","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9573526","rdfs:label":"IV:10","ageType":"AgeAtReport","ageUnit":"Years","ageValue":56,"allele":{"id":"https://genegraph.clinicalgenome.org/r/12f43e11-78d9-4077-b43c-234a16b326fa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.3(PKD2):c.2159dup (p.Asn720LysfsTer5)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA440268375"}},"detectionMethod":"We screened for mutations by directly sequencing two nested RT-PCR fragments (PKD2N1 and PKD2N2) that cover approximately 90% of the PKD2 open reading frame.","firstTestingMethod":"PCR","phenotypes":"obo:HP_0000113","previousTesting":true,"previousTestingDescription":"PKD2 family shown to have linkage to the PKD2-region.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7546bb19-0e75-47f3-bcdf-7cc65f6365f7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9573526","allele":{"id":"https://genegraph.clinicalgenome.org/r/12f43e11-78d9-4077-b43c-234a16b326fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":11,"proband":{"id":"https://genegraph.clinicalgenome.org/r/395ecbff-c2d0-4fce-8cf5-4e4bc69f0084"},"publishedLodScore":4.55,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ba6cc40d-93ca-4326-8d3d-3a26e4f55a7d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","rdfs:label":"Family 1605","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/ba6cc40d-93ca-4326-8d3d-3a26e4f55a7d","type":"Family","rdfs:label":"Family 1605","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/46dc10b5-06ac-4949-b476-481b24746e40","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","rdfs:label":"1605","allele":{"id":"https://genegraph.clinicalgenome.org/r/8317df17-ec9a-45a0-9a5d-68e9fb0e5362","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.2224C>T (p.Arg742Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/13518"}},"detectionMethod":"We used reverse-transcribed RNA and genomic DNA templates to generate polymerase chain reaction (PCR) products for single-strand conformational analysis (SSCA). Genomic PCR products of SSCA variants were subjected to direct sequencing.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"PKD2 family shown to have linkage to the PKD2-region.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/808b482c-5b38-47f6-bf59-4572eef386f3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","allele":{"id":"https://genegraph.clinicalgenome.org/r/8317df17-ec9a-45a0-9a5d-68e9fb0e5362"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"proband":{"id":"https://genegraph.clinicalgenome.org/r/46dc10b5-06ac-4949-b476-481b24746e40"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b240ed57-2986-4ca9-a458-a2534a30d2d4_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650545","rdfs:label":"Family 97 - Segregation Scoring","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/b240ed57-2986-4ca9-a458-a2534a30d2d4","type":"Family","rdfs:label":"Family 97 - Segregation Scoring","ethnicity":{"id":"cg:UnknownEthnicity"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":10,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1cbe10bb-9dba-45e4-b630-cb4bfa9e6256","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1cbe10bb-9dba-45e4-b630-cb4bfa9e6256_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d9422bac-82e0-427b-b413-9238ca60161f","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9422bac-82e0-427b-b413-9238ca60161f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3890e5ca-3125-4caa-bebf-78e92eadb41f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3890e5ca-3125-4caa-bebf-78e92eadb41f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29529603","allele":{"id":"https://genegraph.clinicalgenome.org/r/b2d47e74-9c12-416c-b474-724cc64d31f3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.2495G>C (p.Ser832Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357627077"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1f558c68-f46a-4266-b939-cf1686c02c11","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f558c68-f46a-4266-b939-cf1686c02c11_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23985799","allele":{"id":"https://genegraph.clinicalgenome.org/r/a725fe25-5984-410f-8ffe-bc2c4b870c25","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.1166C>T (p.Ala389Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357615555"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ebaa8ede-0858-4c5b-a5e5-2eaf5f0d7283","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebaa8ede-0858-4c5b-a5e5-2eaf5f0d7283_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23985799","allele":{"id":"https://genegraph.clinicalgenome.org/r/5bffcf84-4c35-4f8b-b574-db21c81e5315","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000297.4(PKD2):c.1174T>G (p.Tyr392Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA357615590"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/808b482c-5b38-47f6-bf59-4572eef386f3","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/808b482c-5b38-47f6-bf59-4572eef386f3_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7546bb19-0e75-47f3-bcdf-7cc65f6365f7","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7546bb19-0e75-47f3-bcdf-7cc65f6365f7_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2132fd7b-d015-435f-bb51-e67914f33734","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2132fd7b-d015-435f-bb51-e67914f33734_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c8fbb192-024a-4102-aa42-1a7c8241b8c9","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c8fbb192-024a-4102-aa42-1a7c8241b8c9_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/ae0ae123-be04-4ba2-b685-594ca47a3467_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae0ae123-be04-4ba2-b685-594ca47a3467_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/451fbc55-214c-4892-b181-4de78de4aaa6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5bfb2d54-fa7b-4e4c-a5dd-1063ea652a9f","type":"Finding","dc:description":"Immunostaining\nof human and murine renal tissues demonstrated widespread and developmentally regulated expression of polycytin-2, with\nhighest levels in the kidney in the thick ascending limbs of the\nloop of Henle and the distal convoluted tubule.  Identical staining\npatterns in human and mouse define polycystin-2 as a developmentally regulated integral membrane protein that localizes\nto the basolateral plasma membranes of renal tubular epithelial\ncells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10770959","rdfs:label":"PKD2 Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6181bd99-1e3d-4dd5-831e-6643ddf1858a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9a57a2b-4d87-44fa-8338-b9c7331298ec","type":"Finding","dc:description":"We investigated the expression pattern of PKD2 transcripts and proteins during human embryogenesis and kidney development,\nusing Northern blot analysis, in situ hybridization,\nand immunohistochemical methods. In human 5- to 6-week-old embryos, PKD2 is widely expressed, mainly in neural tissue,\ncardiomyocytes, endodermal derivatives, and mesonephros. At this age, PKD2 expression\nis observed in the ureteric bud and the uninduced\nmetanephros. Thereafter, PKD2 is diffusely expressed at all stages of nephron development. Proximal tubule expression of PKD2 decreases from weeks 20 to 24\nonwards. Persistent expression of PKD2 transcripts and protein is observed\nthroughout nephrogenesis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11891195","rdfs:label":"PKD2 Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f2be7ff0-af29-45b2-8d32-2ea02cb8686a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/837d61a1-0102-4421-bf0c-12da8f3bc67a","type":"Finding","dc:description":"To begin to elucidate the molecular mechanisms underlying\nADPKD, we evaluated the interaction of PKD1 and PKD2 by\nusing the yeast two-hybrid system and in vivo and in vitro\ncoimmunoprecipitation assays. The association of the two\nproteins in all three systems supports a model in which the two\ngene products participate in a common signaling pathway.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9192675","rdfs:label":"PKD1 interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4ddb9089-5275-407e-a6b3-851d73bc7cd1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd7bce5f-c63c-420f-a9c3-cb879ef065d5","type":"Finding","dc:description":"Targeted deletion of the epidermal growth factor receptor (EGFR) gene by homologous recombination in CD-1 mice\nresulted in cystic dilatation of collecting ducts, an area\nthat is also affected by mutations in the PKD2 gene.\nTherefore, these previous results implied that there might be\nfunctional interaction between EGFR and PKD2 and\nprompted us to test whether PKD2 activity can be directly\nmodulated by epidermal growth factor (EGF) in kidney epithelial cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16135816","rdfs:label":"GFPC","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ae0ae123-be04-4ba2-b685-594ca47a3467_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1537e01-50ae-4809-b0ad-3b0b11ac7e91","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6054375e-1a33-4c34-af5f-57af7d16ce3c","type":"Finding","dc:description":"Pkd2-null mice die during embryogenesis. Pkd2-null mice with a hemizygous human PKD2-transgene allele (Pkd2-/-;PKD2tg) fully rescued the lethal phenotype, suggesting that the human PKD2 was fully functional during mouse development. However, the adult Pkd2-/-;PKD2tg mice still showed cyst formation in the kidney, liver, and pancreas. We therefore hypothesized that the cystic phenotypes were related to the level of functional PKD2 expression, and deduced that allelic increase of the transgene would be beneficial to Pkd2-null mice. Consistent with the hypothesis, we found that mice with homozygous PKD2-transgene alleles (PKD2tg/tg) expressed PC2 at a level double that of the PKD2tg mice, and that the kidney and liver cysts seen in the Pkd2-/-;PKD2tg mice almost disappeared in Pkd2-null mice with homozygous PKD2-transgene alleles (Pkd2-/-;PKD2tg/tg). In addition, the Pkd2-/-;PKD2tg/tg mice also had a greater 12-month\nsurvival rate than the Pkd2-/-;PKD2tg mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26435415","rdfs:label":"Human PKD2 transgene rescue in mice","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/84dd419a-6c07-444b-b60a-85906a324ae8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/baf1e1e5-b841-4359-8fec-3d0084e7d650","type":"Finding","dc:description":"The histologic features of the renal cystic disease in the mutant mice are virtually identical to those described for human ADPKD.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9568711","rdfs:label":"Pkd2 Mutant Mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":7243,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/_X1Xy9yUVto","type":"GeneValidityProposition","disease":"obo:MONDO_0004691","gene":"hgnc:9009","modeOfInheritance":"obo:HP_0000006"},"version":"2.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ae0ae123-be04-4ba2-b685-594ca47a3467-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}